Eugenosedin-A ameliorates hyperlipidemiainduced vascular endothelial dysfunction via inhibition of a1-adrenoceptor/5-HT activity and NADPH oxidase expression

MUIR > Graduate Institute of Health Care > Department of Nursing > Papers > Item 987654321/2479

Please use this identifier to cite or link to this item: http://ir.meiho.edu.tw/ir/handle/987654321/2479

Title:	Eugenosedin-A ameliorates hyperlipidemiainduced vascular endothelial dysfunction via inhibition of a1-adrenoceptor/5-HT activity and NADPH oxidase expression
Authors:	Kuo-Ping Shen;Hui-Li Lin;Wen-Tsan Chang;Jou-Chun Lin;Li-Mei An;Ing-Jun Chen;Bin-Nan Wu
Keywords:	Atorvastatin;Endothelialdysfunction;Eugenosedin-A;Hyperlipidemia;Oxidative markers
Date:	2014
Issue Date:	2014-09-02T03:01:19Z (UTC)
Abstract:	Eugenosedin-A (Eu-A) effects on vascular endothelial dysfunction and oxidativestress in a hyperlipidemic rat model were investigated. Rats were randomly divided into fourgroups: two control groups and two treatment groups. The control rats received a regular dietor high fat diet (HFD); the treatment rats fed received an HFD with 5 mg/kg Eu-A or atorvastatinfor 10 weeks. No changes in serotonin levels were observed in the four groups; norepinephrinelevels were enhanced in the HFD group which was attenuated by Eu-A andatorvastatin. In the HFD group, the vascular reactivity was increased by vasoconstrictors (5-nonyloxytryptamine, 5-HT, and phenylephrine) and decreased by an endothelium-dependentvasorelaxant, carbachol. Protein levels of a1-adrenergic receptors (not 5-HT1B/2A), reactive oxygenspecies (ROS) p47phox, p67phox, and gp91phox, and oxidative damage markers 3-nitrotyrosine (3-NT) and 4-hydroxy-2-nonenal (4-HNE) were increased, but endothelial nitricoxide synthase (eNOS), P-eNOS and vasodilator-stimulated phosphoprotein phosphorylation(P-VASP) were decreased. Catalase and superoxide dismutase (SOD-1 and SOD-2) proteins wereincreased, but glutathione peroxidase (GPx) was decreased in the aorta. Eu-A and atorvastatinreduced vasoconstrictor-induced aortic contractions that might be related to 5-HT1B/2A and a1-adrenergic receptors inhibitory activities. Eu-A and atorvastatin improved eNOS/P-eNOS, PVASP,GPx, and malondialdehyde (MDA) levels, and decreased ROS and oxidative damagemarkers. Taken together, we suggest that Eu-A can ameliorate hyperlipidemia-inducedvascular endothelial dysfunction and oxidative dysregulation.
Relation:	Kaohsiung Journal of Medical Sciences (2014) 30, 116e124
Appears in Collections:	[Department of Nursing] Papers

Files in This Item:

File	Description	Size	Format
KJMS March 2014.pdf	fulltext	694Kb	Adobe PDF	0	View/Open

View Licence

Loading...